San Francisco, California, United States
Contact Info
2K followers
500+ connections
San Francisco, California, United States
Contact Info
2K followers
500+ connections
Articles by Dimitry
Activity
-
Last training ride before Pan-Mass Challenge Ride ! Excited for #PMC2024 where over 7000 riders are focused on 1 mission: Curing Cancer Dana-Farber…
Last training ride before Pan-Mass Challenge Ride ! Excited for #PMC2024 where over 7000 riders are focused on 1 mission: Curing Cancer Dana-Farber…
Liked by Dimitry Nuyten
-
Our KidneyCAN meeting #KCRS24 starts tomorrow with a keynote lecture from Professor Charles Swanton The Francis Crick Institute ! Hans Hammers…
Our KidneyCAN meeting #KCRS24 starts tomorrow with a keynote lecture from Professor Charles Swanton The Francis Crick Institute ! Hans Hammers…
Liked by Dimitry Nuyten
-
In November 2020, Gopinath Palanisamy embarked on his journey with Olema, and today, he serves as our Vice President of Pre-Clinical Pharmacology and…
In November 2020, Gopinath Palanisamy embarked on his journey with Olema, and today, he serves as our Vice President of Pre-Clinical Pharmacology and…
Liked by Dimitry Nuyten
More activity by Dimitry
-
Last week we presented clinical findings at #KCRS24 on our investigational small molecule HIF-2α inhibitor being developed in #kidneycancer. It’s…
Last week we presented clinical findings at #KCRS24 on our investigational small molecule HIF-2α inhibitor being developed in #kidneycancer. It’s…
Liked by Dimitry Nuyten
-
Exceptional #opportunity to join a talented #PV team as #SeniorMedicalDirector, Patient Safety & #Pharmacovigilance responsible for the management of…
Exceptional #opportunity to join a talented #PV team as #SeniorMedicalDirector, Patient Safety & #Pharmacovigilance responsible for the management of…
Liked by Dimitry Nuyten
-
Aktis is pleased to announce the appointment of Akos Czibere MD, PhD, as Chief Medical Officer. Dr. Czibere brings significant clinical and…
Aktis is pleased to announce the appointment of Akos Czibere MD, PhD, as Chief Medical Officer. Dr. Czibere brings significant clinical and…
Liked by Dimitry Nuyten
-
This afternoon, our CMO Dimitry Nuyten will be presenting at KidneyCAN’s #KCRS24 Biotech Showcase where he’ll provide an overview of Arcus’s research…
This afternoon, our CMO Dimitry Nuyten will be presenting at KidneyCAN’s #KCRS24 Biotech Showcase where he’ll provide an overview of Arcus’s research…
Liked by Dimitry Nuyten
-
Congratulations to the team! Thank you for your dedication to the AB598 program
Congratulations to the team! Thank you for your dedication to the AB598 program
Liked by Dimitry Nuyten
-
We are pleased to announce that Taiho Pharmaceutical Co., Ltd., exercised its options for an exclusive license to another Arcus program. We look…
We are pleased to announce that Taiho Pharmaceutical Co., Ltd., exercised its options for an exclusive license to another Arcus program. We look…
Liked by Dimitry Nuyten
-
Economie van de toekomst heeft alles met ruimte te maken. Het College van Rijksbouwmeester en Rijksadviseurs (CRa) pleit in de analyse De economie…
Economie van de toekomst heeft alles met ruimte te maken. Het College van Rijksbouwmeester en Rijksadviseurs (CRa) pleit in de analyse De economie…
Liked by Dimitry Nuyten
-
Day One is thrilled to be featured in Times Square today! The expansion of our pipeline with DAY301 is an exciting milestone to further our mission…
Day One is thrilled to be featured in Times Square today! The expansion of our pipeline with DAY301 is an exciting milestone to further our mission…
Liked by Dimitry Nuyten
-
Today we are excited to share with you our summer magazine, La Rivista. This publication is our annual retrospective that showcases and celebrates…
Today we are excited to share with you our summer magazine, La Rivista. This publication is our annual retrospective that showcases and celebrates…
Liked by Dimitry Nuyten
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More